Table 1 Characteristics and depression rating scores of patients with psychotic depression who responded to fluvoxamine monotherapy
From: Fluvoxamine monotherapy for psychotic depression: the potential role of sigma-1 receptors
| Â | Â | Â | Â | Â | Pretreatment score | Post-treatment score | ||
|---|---|---|---|---|---|---|---|---|
Patient | Gender (F/M) | Age, years | Age at onset, years | Duration of illness | HAM-D | BPRS | HAM-D | BPRS |
Case 1 | F | 72 | 72 | 6 weeks | 34 | 66 | 7 (3 weeks) | 22 (3 weeks) |
Case 2 | F | 54 | 54 | 10 weeks | 42 | 77 | 9 (6 weeks) | 32 (6 weeks) |
Case 3 | M | 67 | 67 | 6 weeks | 45 | 73 | 5 (17 days) | 26 (17 days) |
Case 4 | F | 60 | 60 | 7 weeks | 35 | 69 | 6 (3 weeks) | 22 (3 weeks) |
Case 5 | F | 62 | 62 | 8 weeks | 45 | 80 | 5 (4 weeks) | 22 (4 weeks) |